Zobrazeno 1 - 10
of 21
pro vyhledávání: '"O. E. Fedorova"'
Autor:
T. L. Ragulina, O. E. Fedorova
Publikováno v:
Russian Journal of General Chemistry. 80:2151-2156
The structure and chemical composition of glass fiber surface treatment substances and their influence on composite materials properties are analyzed.
Autor:
Eugene Y. Krynetski, Elena Samochatova, William E. Evans, Natalia V. Chupova, Anastassia Rudneva, Olga A. Maiorova, Tatyana V. Nasedkina, Raul C. Ribeiro, Olga Makarova, O. E. Fedorova, Natalia F. Krynetskaia, Alexander G. Roumyantsev, Andrei S. Glotov, Zh. M. Kozhekbaeva
Publikováno v:
Pediatric Blood & Cancer. 52:203-208
Background Polymorphisms that reduce the activity of thiopurine S-methyltransferase (TPMT) cause adverse reactions to conventional doses of thiopurines, routinely used for antileukemic and immunosuppressive treatment. There are more than 20 variant a
Autor:
R. F. Garkavtseva, Tatiana P. Kazubskaya, O. E. Fedorova, Tatyana V. Nasedkina, Alexander S. Zasedatelev, F. A. Amosenko, L. N. Lyubchenko, Yu. G Payanidi
Publikováno v:
Molecular Biology. 41:32-36
Ovarian cancer (OC) is among the leading causes of cancer-related mortality in women. A high risk of OC (lifetime estimates ranging 10–60%) is determined by BRCA1/2 mutations. The 1100delC variant of CHEK2 is associated with predisposition to breas
Autor:
O. E. Fedorova, Raul C. Ribeiro, Elena Samochatova, Andrei S. Glotov, Victor Barsky, Natalia F. Krynetskaia, Janna M Kozhekbaeva, Olga A. Maiorova, Alexander V. Chudinov, Cheng Cheng, Anastasia E. Roudneva, Natalia V. Chupova, Tatyana V. Nasedkina, Valeria V Zemlyakova, Eugene Y Krynetskiy, Alexander G. Roumyantsev, Roman A Yurasov, William E. Evans, Alexander S. Zasedatelev
Publikováno v:
European Journal of Human Genetics. 14:991-998
Thiopurine drugs are metabolized, in part, by S-methylation catalyzed by thiopurine S-methyltransferase (TPMT). Patients with very low or undetectable TPMT activity are at high risk of severe, potentially fatal hematopoietic toxicity when they are tr
Autor:
O. E. Fedorova, Olga Sinicka, T. V. Nasedkina, Ya. V. Visnevskaya, Laima Tihomirova, Alexander S. Zasedatelev
Publikováno v:
Molecular Biology. 40:25-29
BRCA1 mutations are associated with a higher risk of breast (BC) and ovarian cancer in women. Testing for such mutations allows BC prognosis, selection of an individual treatment strategy, and prevention of disease recurrence. Hybridization on a hydr
Autor:
O. E. Fedorova, G. Y. Pankova, M. I. Mikhailov, V. F. Eremin, E. C. Gorbacheva, B. I. Shevelev, M. S. Balayan, P. G. Rytick, T. I. Danilova
Publikováno v:
Journal of Viral Hepatitis. 4:279-283
Summary. Antibody to hepatitis E virus of IgG class (anti-HEV IgG) is regularly detected in industrialized countries, where HEV is non-endemic, at levels not exceeding 2–3%; seropositive individuals are often found in certain groups of patients and
Autor:
Laima Tihomirova, O. E. Fedorova, Inna Inashkina, Bohdan Górski, Silvija Ozolina, Tatyana V. Nasedkina, Jacek Gronwald, L. N. Lyubchenko, Jan Lubinski, Eriks Jankevics, Olga Sinicka
Publikováno v:
Familial cancer. 8(1)
Uncertainty exists whether the 4154delA mutation of the BRCA1 gene detected in unrelated individuals from Latvia, Poland and Russia is a founder mutation with a common ancestral origin. To trace back this problem we analysed the mutation-associated h
Autor:
O E, Fedorova, L N, Liubchenko, Iu G, Paiadini, T P, Kazubskaia, F A, Amosenko, R F, Gar'kavtseva, A S, Zasedatelev, T V, Nasedkina
Publikováno v:
Molekuliarnaia biologiia. 41(1)
Ovarian cancer (OC) is one of the leading cause of cancer death in women. Inherited BRCA1 and BRCA2 mutations strikingly increase OC risk (with lifetime risk estimates ranging at 10-60%). Mutation 1100delC in CHEK2 gene was shown to be associated wit
Autor:
O E, Fedorova, O N, Sinitska, L P, Tikhomirova, Ia V, Vishnevskaia, A S, Zasedatelev, T V, Nasedkina
Publikováno v:
Molekuliarnaia biologiia. 40(1)
Germ-line mutations in BRCA1 gene account for a substantial proportion of inherited breast and ovarian cancers. Identification of these mutations allows molecular diagnosis for breast cancer susceptibility. We have developed method for identification
Autor:
O E, Fedorova, G I, Alatortseva, N N, Pavlov, O A, Borzykh, R S, Tlenkopachev, L L, Sukhanova, V V, Dotsenko, A V, Titaev, L N, Nesterenko, I I, Amiantova, N A, Zamiatina, V A, Gol'tsov, S N, Kuzin, V V, Zverev
Publikováno v:
Voprosy virusologii. 49(2)
The detection frequency of antibodies to Hepatitis E Virus (HEV) was studied in residents of the South and of the Middle European Part of the Russia Federation as well as of Siberia. Antibodies to HEV were most often found both in patients with hepat